Colorado BioScience Association Names Jack Wheeler Chairperson, Announces 2007 Sponsors and Appoints Eight New Board Members
Summary
Silver – Faegre & Benson L.L.P, Pfizer, Fitzsimons Redevelopment Authority, Ernst & Young, ABD Insurance and Financial Services, Metro Denver Economic Development Corporation, Gambro, and Snell & Wilmer, L.L.P.* Michael Salem, M.D., FACS, began his tenure as President and CEO of National Jewish Medical and Research Center (http://www.njc.org) in January 2006, bringing to the position a combination of academic and business experience in the healthcare field.Silver – Faegre & Benson L.L.P, Pfizer, Fitzsimons Redevelopment Authority, Ernst & Young, ABD Insurance and Financial Services, Metro Denver Economic Development Corporation, Gambro, and Snell & Wilmer, L.L.P.New CBSA board members receiving three-year appointments include: Derek Cole, Allos Therapeutics; Doug Henston, Solix Biofuels; Chris Lepore, Johnson & Johnson; Dan Mitchell, Sequel Venture Partners; Harry Ross, Aweida Venture Partners; Michael Salem, National Jewish Medical and Research Center; Greg Tucker, OSI Pharmaceuticals; and M. Roy Wilson, University of Colorado.Bios follow of the newly appointed board members:* Derek Cole, Vice President Investor Relations for Allos Therapeutics (http://www.allos.com) has been involved in the capital markets and strategic planning for over 16 years with 11 years of dedicated investor relations experience focused on supporting the development of small- and mid-cap companies.* Michael Salem, M.D., FACS, began his tenure as President and CEO of National Jewish Medical and Research Center (http://www.njc.org) in January 2006, bringing to the position a combination of academic and business experience in the healthcare field.